SLC2A1 and neoplasm: Current PET-CT technologies use 18F-deoxyglucose as a tracer for cancer imaging, based on the tumor-specific upregulation of glucose transporter-1 (GLUT-1; also known as SLC2A1) on tumor cells [82].